For the Inventor, By the Inventor

Enter assignee name

Richmond, CA, United States of America

Berlex Laboratories, Inc.

USPTO Granted Patents = 100

% Expired Patents = 15.0

Forward Citations = 1,938

Loading Chart...

Loading Chart...

99 inventors (with patents filed for the assignee):

Michael M Morrissey (49 out of 73 patents)

Gary Bruce Phillips (31 out of 81 patents)

Howard P Ng (25 out of 76 patents)

4. David D Davey (23 out of 43 patents)

5. Raju Mohan (18 out of 77 patents)

6. Brad Owen Buckman (17 out of 47 patents)

7. Monica J Kochanny (17 out of 27 patents)

8. Shung C Wu (15 out of 29 patents)

9. William J Guilford (13 out of 39 patents)

10. Wei Xu (12 out of 81 patents)

11. Zuchun Zhao (12 out of 39 patents)

12. Damian O Arnaiz (11 out of 23 patents)

13. Bin Ye (10 out of 22 patents)

14. Kenneth Jay Shaw (9 out of 19 patents)

15. James J Devlin (7 out of 39 patents)

Core Competencies:

Anti-Coagulants

Benzamidine Derivatives

N-Heterocyclic Derivatives

Polyhydroxylated Compounds

Aryl Substituted Pyrimidines

Thio Acid Derivatives

Somatostatin Analogs

Scintigraphic Imaging Agents

Chronic Muscle Pain Treatment

Ultra-Low Dose Therapies

Interferon Production

Chemical Reaction Apparatus

100 patents: Sort by Forward Citations

1. 6887865 - N-heterocyclic derivatives as NOS inhibitors (2005-05-03),

2. 6884418 - Use of ligand-mimicking agents and anti-neoplastic drugs in cancer therapy (2005-04-26),

3. 6864368 - N-heterocyclic derivatives as NOS inhibitors (2005-03-08),

4. 6864263 - N-heterocyclic derivatives as NOS inhibitors (2005-03-08),

5. 6849739 - N-heterocyclic derivatives as NOS inhibitors (2005-02-01),

6. 6846829 - N-heterocyclic derivatives as NOS inhibitors (2005-01-25),

7. 6841674 - N-heterocyclic derivatives as NOS inhibitors (2005-01-11),

8. 6841673 - N-heterocyclic derivatives as nos inhibitors (2005-01-11),

9. 6686367 - Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants (2004-02-03),

10. 6686364 - Benzamidine derivatives and their use as anti-coagulants (2004-02-03),

11. 6559147 - Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants (2003-05-06),

12. 6552030 - Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants (2003-04-22),

13. 6498185 - Ortho-anthranilamide derivatives as anti-coagulants (2002-12-24),

14. 6495684 - Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants (2002-12-17),

15. 6495574 - Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants (2002-12-17),

Berlex Laboratories, Inc. is a pharmaceutical company specializing in the research, development, and production of innovative medicines. Our mission is to improve patient health and well-being by delivering high-quality medications that address unmet medical needs. With a strong focus on scientific excellence and collaboration, we strive to discover breakthrough therapies in various therapeutic areas. Visit our website to learn more about our portfolio, pipeline, and commitment to advancing healthcare.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 22 2026

100 Patents

#3 in Richmond, CA

#866 in California

#3,788 in US

#7,765 in the World

Richmond, CA, United States of America

Berlex Laboratories, Inc.

Forward Citations = 1,938

99 inventors:

Michael M Morrissey (49 out of 73 patents)

Gary Bruce Phillips (31 out of 81 patents)

Howard P Ng (25 out of 76 patents)

4. David D Davey (23 out of 43 patents)

5. Raju Mohan (18 out of 77 patents)

Please report any incorrect information to [email protected]

Loading…